The NRF2-LOC344887 signaling axis suppresses pulmonary fibrosis
暂无分享,去创建一个
Donna D. Zhang | Yongyi Wei | E. Chapman | P. Liu | M. Dodson | Joe G. N. Garcia | Aikseng Ooi | Gang Luo | Cody J. Schmidlin | Pengfei Liu | Barış Kerimoğlu
[1] Kacper Lechowicz,et al. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection , 2020, Journal of clinical medicine.
[2] A. Wells,et al. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.
[3] Donna D. Zhang,et al. NRF2 negatively regulates primary ciliogenesis and hedgehog signaling , 2020, PLoS biology.
[4] M. Kreuter,et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. , 2020, The Lancet. Respiratory medicine.
[5] H. Lou,et al. Trans-4,4'-dihydroxy stilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response. , 2019, Free radical biology & medicine.
[6] Roshini Sathiaseelan,et al. lncRNA FENDRR Exhibits Anti-Fibrotic Activity in Pulmonary Fibrosis. , 2019, American journal of respiratory cell and molecular biology.
[7] Donna D. Zhang,et al. Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation. , 2019, Cell chemical biology.
[8] G. Raghu,et al. Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis , 2019, European Respiratory Review.
[9] Abdullahi Umar Ibrahim,et al. Genome Engineering Using the CRISPR Cas9 System , 2019 .
[10] E. Wagner,et al. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation. , 2019, The Journal of clinical investigation.
[11] Huan Wang,et al. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140 , 2019, Molecular and Cellular Biology.
[12] Lei Wang,et al. Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress , 2019, Redox biology.
[13] Donna D. Zhang,et al. Redox regulation by NRF2 in aging and disease. , 2019, Free radical biology & medicine.
[14] Wei Peng,et al. lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial–mesenchymal transition by competitively binding miR-141-3p , 2019, Cell Death & Disease.
[15] Qinqin Jin,et al. Polydatin attenuates reactive oxygen species‐induced airway remodeling by promoting Nrf2‐mediated antioxidant signaling in asthma mouse model , 2019, Life sciences.
[16] Jian Gao,et al. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT‐mediated PF , 2018, Journal of cellular physiology.
[17] Xiaoguang Sun,et al. RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE–dependent repression , 2018, Proceedings of the National Academy of Sciences.
[18] Donna D. Zhang,et al. NRF2 and the Hallmarks of Cancer. , 2018, Cancer cell.
[19] Honggang Zhou,et al. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway , 2018, Respiratory Research.
[20] G. Raghu,et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? , 2018, The Lancet. Respiratory medicine.
[21] Q. Cui,et al. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis , 2018, Diabetes.
[22] J. Mendell,et al. Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.
[23] Jian Gao,et al. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial–mesenchymal transition during pulmonary fibrosis , 2018, Cell Death & Disease.
[24] J. Salciccioli,et al. Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 , 2018, European Respiratory Journal.
[25] Qi Zhang,et al. The NmrA‐like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial–mesenchymal transition , 2017, Chemical biology & drug design.
[26] David E. Williams,et al. A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane‐treated colon cancer cells , 2017, Molecular nutrition & food research.
[27] P. Liu,et al. p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex , 2017, Molecular and Cellular Biology.
[28] R. Ruggiero,et al. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review. , 2016, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[29] H. Yao,et al. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis , 2016, Scientific Reports.
[30] A. Günther,et al. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. , 2016, The Lancet. Respiratory medicine.
[31] B. Herrmann,et al. Mechanisms of long noncoding RNA function in development and disease , 2016, Cellular and Molecular Life Sciences.
[32] Donna D. Zhang,et al. Artemisitene activates the Nrf2‐dependent antioxidant response and protects against bleomycin‐induced lung injury , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Takafumi Suzuki,et al. Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.
[34] Lydia Han,et al. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. , 2015, European review for medical and pharmacological sciences.
[35] L. Norton,et al. N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties , 2014, Oncogene.
[36] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[37] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[38] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[39] Howard Y. Chang,et al. Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.
[40] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[41] R. Kemler,et al. Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation , 2011, Breast Cancer Research.
[42] P. Wong,et al. Dual roles of Nrf2 in cancer. , 2008, Pharmacological research.
[43] Hye-Youn Cho,et al. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. , 2008, Antioxidants & redox signaling.
[44] B. Beghé,et al. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis. , 2004, Respiratory medicine.
[45] T. Baba,et al. Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience. , 2017, Respiratory investigation.
[46] Irene M Spinello,et al. Pulmonary coccidioidomycosis. , 2008, Seminars in respiratory and critical care medicine.
[47] P. Batra,et al. Pulmonary coccidioidomycosis. , 1992, Journal of thoracic imaging.